hit counter

Alzheimer’s Plasma Protein Structure Panel Reached AUCs Above 0.93

MHD featured image for Alzheimer's plasma protein-structure biomarkers.

A 2026 Nature Aging study involving 520 participants found that plasma protein-structure signatures classified healthy control, mild cognitive impairment, and Alzheimer’s disease groups with 83.44% three-way accuracy.1 The result is a serious biomarker signal, but it is not a clinic-ready replacement for established Alzheimer’s testing. Research Highlights Classification was strong: The plasma structural-proteomics panel reached …

Read more

SPP1 Marks Cross-Disease Microglial Activation in Neurodegeneration

MHD featured image for SPP1 microglia and neurodegeneration transcriptomics.

A 2026 Glia analysis found a shared microglial transcriptional program across 5 neurodegenerative contexts: ALS, frontotemporal dementia, Alzheimer’s disease, aging, and Parkinson’s disease.1 The standout marker was SPP1, a gene encoding osteopontin, but the finding is a cellular-state signal rather than a ready diagnostic test. Research Highlights Cross-disease microglia converged: the integrated dataset covered ALS, …

Read more

Lower Uric Acid Predicted Depression in Prodromal Parkinson’s Disease

MHD featured image for uric acid and depression risk in prodromal Parkinson's disease.

A 5-year PPMI cohort analysis found that lower serum uric acid independently predicted incident depression in prodromal Parkinson’s disease (HR = 0.776; 95% CI 0.619-0.974; P = 0.029).1 The signal sits beside a lower-p-value non-motor symptom predictor: higher MDS-UPDRS Part I scores also predicted depression (HR = 1.177; 95% CI 1.093-1.267; P < 0.001). Research ...

Read more

Trichostatin A for Alzheimer’s: 8 Core Genes, Unstable Binding

MHD featured image for Trichostatin A and Alzheimer's disease gene networks.

A 2026 PLOS One computational study linked Trichostatin A to 949 predicted targets and 8 machine-learning-selected Alzheimer’s disease core genes, but 100 ns molecular dynamics simulations suggested the compound did not stably bind those candidate proteins.1 That makes the result more useful as an epigenetic network hypothesis than as evidence for a near-term Alzheimer’s drug. …

Read more

CoQ10 Preserved Working Memory in Drp1-Deficient Mice Through Coa6

MHD featured image for CoQ10, working memory, Drp1 deficiency, Coa6, and mitochondrial respiratory-chain function.

A 2026 mouse study found that long-term CoQ10 exposure reduced working-memory errors in Purkinje-cell-specific Drp1-deficient mice, tying the behavioral rescue to Coa6 binding and support for mitochondrial respiratory-chain function.1 The result supports a narrow mechanistic CoQ10-Coa6 pathway under neuronal mitochondrial dysfunction while leaving human memory-supplement claims untested. Research Highlights Working memory improved in a mouse …

Read more

Blood microRNAs Linked to Hippocampal Atrophy in Rhineland Study

MHD featured image for blood microRNA signatures and hippocampal atrophy.

A 2026 Molecular Psychiatry analysis from the Rhineland Study found that blood-derived microRNA signatures were associated with hippocampal brain structure: 6 microRNAs linked cross-sectionally to left hippocampal volume, and 5 different microRNAs linked longitudinally to hippocampal atrophy rates.1 The result is biomarker-discovery evidence for brain aging, not a ready dementia blood test. Research Highlights Baseline …

Read more

Under-Mattress Sensors Predict Dementia Agitation: 333-Night Cohort

Stylized illustration of an under-mattress sensor connected to a clock and waveform pattern, indicating overnight respiratory and movement signals predicting next-day behavioral risk in a dementia care setting.

Daytime agitation in dementia fluctuates day-to-day, and a 2026 explanatory study from Liu et al. used contactless under-mattress sensors in 55 long-term-care residents and an external 17-person home-monitoring cohort to show that lower nocturnal respiratory rate and higher activity instability robustly predict next-day agitation occurrence — but not severity.1 Research Highlights Lower breathing rate: adjusted …

Read more